FY2025 · ended Dec 31, 2025 · Revenue $1.78B, -3.7% YoY · Filed Feb 18, 2026
Innospec Inc. (IOSP) files with the SEC under industry code 2800, Chemicals & Allied Products. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.8 billion and net income of $116.6 million. As of Sep 30, 2026 it held $251.9 million in cash and investments and $47.3 million in total debt.
Revenue (TTM)
$1.87B
+4.7% vs year-ago TTM
Net income
$116.60M
+227.5% vs prior year
Operating cash flow (TTM)
$102.60M
-1.0% vs year-ago TTM
Free cash flow
$50.30M
-4.6% vs prior year
EPS
$4.67
+228.9% vs prior year
Dividend per share (TTM)
$1.71
+4.9% vs year-ago TTM
Shares outstanding
24.78M
-0.7% vs prior year
Net cash
$204.60M
as of Sep 30, 2026
Operating margin
8.8%
FY 2026
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- IOSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Englewood, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1054905
- Former names
- OCTEL CORP (until Jan 9, 2006)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Chemours Co CC
- OLIN Corp OLN
- Huntsman CORP HUN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $1.8B | $1.9B | $2.0B | $1.5B |
| Operating income | $129.5M | $177.9M | $161.6M | $187.3M | $132.1M |
| Net income | $116.6M | $35.6M | $139.1M | $133.0M | $93.1M |
| Diluted EPS | $4.67 | $1.42 | $5.56 | $5.32 | $3.75 |
| Operating cash flow | $138.3M | $184.5M | $207.3M | $81.7M | $93.2M |
| Total assets | $1.8B | $1.7B | $1.7B | $1.6B | $1.6B |
| Total liabilities | $499.5M | $518.6M | $557.8M | $563.3M | — |
| Stockholders' equity | $1.3B | $1.2B | $1.1B | $1.0B | $1.0B |
| Cash and investments | $292.5M | $289.2M | $203.7M | $147.1M | $141.8M |
| Total debt | $52.7M | $44.9M | $45.2M | $45.3M | $35.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2026 | May 8, 2026 |
All 1009 Innospec Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.